Evotec SE (EVO) FCF Payout Ratio (QoQ) (2009 - 2025)
Evotec SE (EVO) FCF Payout Ratio (QoQ) (2009 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.85 Bn | 39.19 Bn | 2.15 Bn |
| 3 | Zoetis | 31.40 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.42 Bn | 15.03 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - |
| 10 | Evotec SE | 689.00 Mn | 688.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 590.10% |
| Jun 30, 2025 | 98.18% |
| Sep 30, 2024 | -99.00% |
| Jun 30, 2024 | 125.23% |
| Sep 30, 2023 | 75.35% |
| Jun 30, 2023 | 103.42% |
| Sep 30, 2022 | 467.12% |
| Jun 30, 2022 | -97.27% |
| Sep 30, 2021 | 1,072.72% |
| Jun 30, 2021 | -99.99% |
| Sep 30, 2010 | 55.47% |
| Jun 30, 2010 | -10,162.53% |
| Mar 31, 2010 | 105.14% |
| Jun 30, 2009 | 524.01% |